73672-02-3

Basic information

• Product Name: pregnenolone 21-pyridinium iodide
• Synonyms: pregnenolone 21-pyridinium iodide
• CAS NO: 73672-02-3
• Molecular Weight: 521.482
• Mol File: 73672-02-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: pregnenolone 21-pyridinium iodide(CAS DataBase Reference)
• NIST Chemistry Reference: pregnenolone 21-pyridinium iodide(73672-02-3)
• EPA Substance Registry System: pregnenolone 21-pyridinium iodide(73672-02-3)

Safety Data

• Hazardous Substances Data: 73672-02-3(Hazardous Substances Data)

Upstream product

• 110-86-1 pyridine 
• 145-13-1 Pregnenolone 

Downstream Products

• 160001-82-1 (1S,3aS,4S,5S,7aS)-4-Chlorocarbonylmethyl-7a-methyl-5-((1R,4S)-1-methyl-2-oxo-4-triisopropylsilanyloxy-cyclohexyl)-octahydro-indene-1-carboxylic acid methyl ester 
• 151520-57-9 (1S,3aS,4S,5S,7aS)-4-Carboxymethyl-7a-methyl-5-((1R,4S)-1-methyl-2-oxo-4-triisopropylsilanyloxy-cyclohexyl)-octahydro-indene-1-carboxylic acid methyl ester 
• 1402153-80-3 (2R,8S,9S,10R,13S,14S,17S)-2-(4-chlorobenzyl)-17-(4-hydroxybenzoyl)-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-carboxylic acid 
• 1402154-12-4 (2R,8S,9S,10R,13S,14S,17S)-methyl 2-(4-chlorobenzyl)-17-(4-hydroxybenzoyl)-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-carboxylate 
• 1402154-11-3 (2R,8S,9S,10R,13S,14S,17S)-methyl 17-(4-hydroxybenzoyl)-2,10,13-trimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-carboxylate 
• 1402154-05-5 (2R,8S,9S,10R,13S,14S,17S)-methyl 2-(4-chlorobenzyl)-10,13-dimethyl-17-[(pyridin-2-ylthio)carbonyl]-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-carboxylate 
• 1402154-08-8 (2R,8S,9S,10R,13S,14S,17S)-methyl 2-benzyl-10,13-dimethyl-17-[(pyridin-2-ylthio)carbonyl]-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-carboxylate 
• 1402153-98-3 (2R,8S,9S,10R,13S,14S,17S)-2-(4-chlorobenzyl)-3-(methoxycarbonyl)-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylic acid 
• 1402154-01-1 (2R,8S,9S,10R,13S,14S,17S)-2-benzyl-3-(methoxycarbonyl)-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylic acid 
• 1402153-91-6 (2R,8S,9S,10R,13S,14S,17S)-17-tert-butyl 3-methyl 2-(4-chlorobenzyl)-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dicarboxylate 
• 1402153-94-9 (2R,8S,9S,10R,13S,14S,17S)-17-tert-butyl 3-methyl 2-benzyl-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dicarboxylate 
• 1402154-20-4 (2S,8S,9S,10R,13S,14S,17S)-tert-butyl 10,13-dimethyl-3-oxo-2-[4-(trifluoromethyl)benzyl]-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1Hcyclopenta[a]phenanthrene-17-carboxylate 
• 1402153-86-9 (2R,8S,9S,10R,13S,14S,17S)-tert-butyl 10,13-dimethyl-3-oxo-2-[4-(trifluoromethyl)benzyl]-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1Hcyclopenta[a]phenanthrene-17-carboxylate 
• 1402154-19-1 (2S,8S,9S,10R,13S,14S,17S)-tert-butyl 2-(4-tert-butylbenzyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylate 

Relevant articles and documents

AZASTEROIDS FOR TREATMENT OF TUBERCULOSIS

The present invention provides a compound having the structure: formula (I), for use in combinatoin with an anti-tuberculosis drug for treating a subject infected with M. tuberculosis.

Anti-AIDS agents. Part 36: 17-carboxylated steroids as potential anti-HIV agents

In our search for novel anti-HIV agents, seven 17-carboxylated steroid derivatives were synthesized and evaluated as potential anti-HIV agents. Compound 13 exhibited potent anti-HIV activity in acutely infected H9 lymphocytes with EC50 and therapeutic index values of 0.8 μM and 300, respectively.

Azasteroids as Inhibitors of Rat Prostatic 5α-Reductase

A series of A-ring heterocyclic steroids has been prepared and tested for inhibition of rat prostatic steroid 5α-reductase in vitro.Strinkingly high inhibitory activity was found with a group of 17β-substituted 4-methyl-4-aza-5α-androstan-3-ones.These compounds were prepared from 3-keto-Δ4-precursors by oxidative (O3 or NaIO4-KMnO4) A-ring cleavage followed, in turn, by ring closure with an amine and hydrogenation over platinum catalyst.Other A-ring azasteroids were made by Beckmann rearrangement of oximes of 2-oxo-A-nor-, 3-oxo- and 4-oxo-5α-androstanes.An A-nor-2-oxo-3-azasteroid was prepared by oxidative decarbonylation of a precursor 2,3-dioxo-4-azasteroid with m-chloroperbenzoic acid.A-ring modifications of the 4-azasteroids included Δ1-unsaturation, 2- and 4-substituents, and 3-carbonyl replacements.Side chains at the 17-position were varied with an emphasis on carboxylate derivatives (salts, esters, and amides).